ReviewCurrent drug targets2008
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
Jeff S Isenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewCurrent drug targets2008
Jeff S Isenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.